‘I’m not gonna do this again’, we often say when faced with negative feedback, adverse effects, or disappointing outcomes. Thus, we attempt to learn from such negative experiences.
Peripheral IV Access for Chemo Better Than Central Lines in Testicular Cancer?
Patients with testicular cancer had fewer venous access-related complications and overall thrombotic events when first-line chemotherapy was delivered via peripheral intravenous access compared with central
January 31, 2024